Astaxanthin, a Natural Antioxidant, Lowers Cholesterol and Markers of Cardiovascular Risk in Individuals with Prediabetes and Dyslipidemia.

Theodore P CiaraldiSchafer C BoederSunder R MudaliarErin R GiovannettiRobert R HenryJeremy H Pettus

Published in: Diabetes, obesity & metabolism (2023)

Although the primary endpoint did not meet the prespecified significance level, these data suggest that astaxanthin is a safe OTC supplement that improves lipid profiles and markers of CVD risk in individuals with prediabetes and dyslipidemia. This article is protected by copyright. All rights reserved.

Keyphrases

oxidative stress
electronic health record
big data
anti inflammatory
machine learning
low density lipoprotein
data analysis